Among psychotropic drugs, sleeping pills have nothing to do with Parkinson’s disease.
Drugs used to relieve depression and anxiety may cause Parkinson’s disease in women over the age of 65, a study has found.
A joint research team from the University of Tennessee, University of Iowa, and Fort Bellevwer Military Hospital in the U.S. analyzed the use of psychotropic drugs and Parkinson’s disease among 53,996 women 65 years of age and older, collected from 1993 to 1998 in the Women’s Health Initiative (WHI). analyzed the relevance of WHI is a women’s health program supported by the National Institutes of Health (NIH).
The researchers found an association between the use of psychotropic drugs, particularly antidepressants and anti-anxiety drugs, and the development of Parkinson’s disease in women over the age of 65, the researchers said. Postmenopausal women are at increased risk for diseases that require the use of psychotropic placebos. Women over 65 years of age make up the majority of patients with late-onset Parkinson’s disease, with more severe symptoms, faster disease progression, and shorter survival times.
The research team followed the subjects for an average of 14.4 years, and provided information on psychotropic drug use to 17,266 women. Of the total subjects, 1756 (regarding 3.3%) had Parkinson’s disease. It was found that 15% of the subjects took antidepressants, 7% took antianxiety drugs, and 8% took sleeping pills. The use of antidepressants and antianxiety drugs significantly increased the risk of developing Parkinson’s disease, but sleeping pills were not associated with the development of Parkinson’s disease. In addition, patients who took one drug had an approximately 50% higher risk of developing Parkinson’s disease than those who did not take the drug at all. However, taking two or more drugs has been shown to increase the risk of Parkinson’s disease by regarding 150%.
The results of this study (Psychotropic medication use and Parkinson’s disease risk amongst older women) were published in the Annals of Clinical and Translational Neurology and were introduced by Parkinson’s News Today.
By Kim Young-seop, staff reporter [email protected]
ⓒ ‘Honest knowledge for health’ Comedy.com (https://kormedi.com) / Unauthorized reproduction-redistribution prohibited
